CIBC Private Wealth Group LLC Sells 519 Shares of Humana Inc. (NYSE:HUM)

CIBC Private Wealth Group LLC lessened its position in shares of Humana Inc. (NYSE:HUM) by 23.1% in the fourth quarter, HoldingsChannel.com reports. The fund owned 1,728 shares of the insurance provider’s stock after selling 519 shares during the period. CIBC Private Wealth Group LLC’s holdings in Humana were worth $463,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in the company. Pinnacle Wealth Management Advisory Group LLC lifted its stake in Humana by 3.6% during the fourth quarter. Pinnacle Wealth Management Advisory Group LLC now owns 1,070 shares of the insurance provider’s stock worth $272,000 after purchasing an additional 37 shares during the last quarter. Atlas Brown Inc. boosted its stake in Humana by 0.6% in the fourth quarter. Atlas Brown Inc. now owns 6,352 shares of the insurance provider’s stock valued at $1,611,000 after buying an additional 38 shares in the last quarter. Mather Group LLC. grew its position in Humana by 21.0% in the fourth quarter. Mather Group LLC. now owns 236 shares of the insurance provider’s stock valued at $60,000 after acquiring an additional 41 shares during the last quarter. Capital Advisors Ltd. LLC raised its stake in Humana by 26.1% during the fourth quarter. Capital Advisors Ltd. LLC now owns 208 shares of the insurance provider’s stock worth $53,000 after acquiring an additional 43 shares in the last quarter. Finally, Retirement Planning Co of New England Inc. lifted its holdings in shares of Humana by 4.7% in the fourth quarter. Retirement Planning Co of New England Inc. now owns 966 shares of the insurance provider’s stock worth $245,000 after acquiring an additional 43 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on HUM shares. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $290.00 price target on shares of Humana in a report on Wednesday, February 12th. JPMorgan Chase & Co. dropped their price target on Humana from $257.00 to $256.00 and set a “neutral” rating for the company in a research note on Tuesday, February 18th. StockNews.com lowered Humana from a “buy” rating to a “hold” rating in a research report on Tuesday, March 18th. Piper Sandler increased their target price on Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a research report on Wednesday, January 15th. Finally, Royal Bank of Canada restated an “outperform” rating and set a $283.00 price target on shares of Humana in a report on Wednesday, February 12th. Eighteen investment analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat.com, Humana presently has a consensus rating of “Hold” and a consensus target price of $280.17.

Humana Stock Down 4.6 %

Shares of NYSE:HUM opened at $253.37 on Friday. The business’s 50-day moving average is $267.58 and its 200-day moving average is $271.85. Humana Inc. has a 1 year low of $213.31 and a 1 year high of $406.46. The company has a market capitalization of $30.58 billion, a price-to-earnings ratio of 25.46, a P/E/G ratio of 2.05 and a beta of 0.62. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76.

Humana (NYSE:HUM) last posted its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. Equities research analysts predict that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.40%. The ex-dividend date of this dividend is Friday, March 28th. Humana’s dividend payout ratio (DPR) is currently 35.58%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.